Investors' valuation of global product design and development

被引:12
|
作者
Ojah, K
Monplaisir, L
机构
[1] Wayne State Univ, Dept Ind & Mfg Engn, Detroit, MI 48202 USA
[2] United Arab Emirates Univ, Coll Business & Econ, Al Ain, U Arab Emirates
关键词
global product design and development; investors' valuation; strategic initiative; multinationalism; IT/IS infrastructure; strategic alliance;
D O I
10.1057/palgrave.jibs.8400049
中图分类号
F [经济];
学科分类号
02 ;
摘要
Stock price responses to 170 announcements about global product design and development (GPDD) by NYSE, AMEX, and Nasdaq firms are significantly positive. This indicates that GPDD, which is fast becoming a strategic initiative of choice for multinational firms in the face of globalization and short time-to-market, is value-enhancing. The value enhancement is strong when announcing firms have a high level of information technology/systems infrastructure and a wide geographical spread of operation, and respond aggressively to their peers' strategic initiatives. Further, cross-sectional analyses show that firms' product market structure, their peers' competitive strategy posture, and whether they produce a good or a service, jointly determine the variation of excess returns attributable to global product development.
引用
收藏
页码:457 / 472
页数:16
相关论文
共 50 条
  • [1] Investors' valuation of global product design and development
    K Ojah
    L Monplaisir
    [J]. Journal of International Business Studies, 2003, 34 : 457 - 472
  • [2] Strategic Competition, Valuation, Costs and Growth Potential: The Example of Global Product Design and Development
    Monplaisir, Leslie
    Malikane, Christopher
    Ojah, Kalu
    [J]. MULTINATIONAL BUSINESS REVIEW, 2009, 17 (01) : 47 - 71
  • [3] VALUATION OF PRODUCT ADAPTABILITY IN ARCHITECTURE DESIGN
    Schrieverhoff, P.
    de Neufville, R.
    Lindemann, U.
    [J]. DS 77: PROCEEDINGS OF THE DESIGN 2014 13TH INTERNATIONAL DESIGN CONFERENCE, VOLS 1-3, 2014, : 373 - 384
  • [4] Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors
    Michaeli, Daniel Tobias
    Yagmur, Hasan Basri
    Achmadeev, Timur
    Michaeli, Thomas
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (02) : 313 - 322
  • [5] Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors
    Daniel Tobias Michaeli
    Hasan Basri Yagmur
    Timur Achmadeev
    Thomas Michaeli
    [J]. Therapeutic Innovation & Regulatory Science, 2022, 56 : 313 - 322
  • [6] In This Issue: Active Investors and Valuation
    不详
    [J]. Journal of Applied Corporate Finance, 2016, 28 (03) : 2 - 3
  • [7] The valuation of franking credits to investors
    Minney, Aaron
    [J]. JASSA-THE FINSIA JOURNAL OF APPLIED FINANCE, 2010, (02): : 29 - 34
  • [9] The Market Valuation of Outsourcing New Product Development
    Raassens, Neomie
    Wuyts, Stefan
    Geyskens, Inge
    [J]. JOURNAL OF MARKETING RESEARCH, 2012, 49 (05) : 682 - 695
  • [10] Product Family Design Based on Real Options Valuation
    Jiao, Jianxin
    Lim, Ching Moi
    Kumar, Arun
    [J]. LEADING THE WEB IN CONCURRENT ENGINEERING: NEXT GENERATION CONCURRENT ENGINEERING, 2006, 143 : 671 - 678